摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-amino-4-(3-nitro-phenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester | 50626-62-5

中文名称
——
中文别名
——
英文名称
2-amino-4-(3-nitro-phenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester
英文别名
2-Amino-4-(3-nitrophenyl)-1,4,5,6,7,8-hexahydro-5-oxoquinoline-3-carboxylic acid ethyl ester;ethyl 2-amino-4-(3-nitrophenyl)-5-oxo-4,6,7,8-tetrahydro-1H-quinoline-3-carboxylate
2-amino-4-(3-nitro-phenyl)-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester化学式
CAS
50626-62-5
化学式
C18H19N3O5
mdl
——
分子量
357.366
InChiKey
LXAIKYRVRSBQOX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >260 °C
  • 沸点:
    581.3±50.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    26
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    127
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • 2-Amino-1,4-dihydropyridine derivatives
    申请人:Bayer Aktiengesellschaft
    公开号:US03935223A1
    公开(公告)日:1976-01-27
    2-Amino-1,4-dihydropyridines bearing a carbonyl function in the 5-position and being optionally substituted by lower alkyl or phenyl in the 6-position, and the corresponding 2-amino-1,4,5,6,7,8-hexahydro-5-oxoquinolines, which derivatives are further substituted by a carbonyl group in the 3-position and optionally substituted in the 4-position by lower alkyl, phenyl, substituted phenyl or a heterocyclic group are anti-hypertensive agents and coronary vessel dilators. The compounds, of which 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3,5-diethyl ester is a representative embodiment, are prepared through condensation of an ylideneacetoacetic acid ester and an amidine.
    在5位带有羰基功能,6位可选择性地被低烷基或苯基取代的2-基-1,4-二氢吡啶和相应的2-基-1,4,5,6,7,8-六氢-5-氧代喹啉,其衍生物在3位进一步取代了羰基基团,4位可选择性地被低烷基、苯基、取代苯基或杂环基团取代,这些化合物是抗高血压药和冠状血管扩张剂。这些化合物通过酰乙酸乙酯氨基嘧啶的缩合反应制备,其中2-基-6-甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸乙酯是代表性实施例。
  • 2-Amino-4-pyrimidyl-1,4-dihydropyridine derivatives
    申请人:Bayer Aktiengesellschaft
    公开号:US04022898A1
    公开(公告)日:1977-05-10
    2-Amino-1,4-dihydropyridines bearing a carbonyl function in the 5-position and being optionally substituted by lower alkyl or phenyl in the 6-position, and the corresponding 2-amino-1,4,5,6,7,8-hexahydro-5-oxoquinolines, which derivatives are further substituted by a carbonyl group in the 3-position and optionally substituted in the 4-position by lower alkyl, phenyl, substituted phenyl or a heterocyclic group are antihypertensive agents and coronary vessel dilators. The compounds, of which 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3,5-diethyl ester is a representative embodiment, are prepared through condensation of an ylideneacetoacetic acid ester and an amidine.
    在5位带有羰基功能并在6位可选择取代为较低烷基或苯基的2-基-1,4-二氢吡啶和相应的2-基-1,4,5,6,7,8-六氢-5-氧喹啉生物,其衍生物在3位进一步取代为羰基基团并在4位可选择取代为较低烷基、苯基、取代苯基或杂环基团,可作为降压剂和冠状血管扩张剂。这些化合物通过酰乙酰乙酸酯和的缩合反应制备,其中2-基-6-甲基-4-(3-硝基苯基)-1,4-二氢吡啶-3,5-二羧酸3,5-二乙酯是一个代表性的实施例。
  • WAMHOFF, HEINRICH;PAASCH, JOACHIM, LIEBIGS ANN. CHEM.,(1990) N0, C. 995-999
    作者:WAMHOFF, HEINRICH、PAASCH, JOACHIM
    DOI:——
    日期:——
  • US3939171A
    申请人:——
    公开号:US3939171A
    公开(公告)日:1976-02-17
  • US3946026A
    申请人:——
    公开号:US3946026A
    公开(公告)日:1976-03-23
查看更多